Precigen Quarterly Balance Sheet
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Precigen financial position
As of Jun 30, 2026, Precigen reported total assets of $170.3 million, up 67.1% from a year earlier against total liabilities of $126.7 million. Shareholders' equity stood at $43.6 million, or 25.6% of assets. The company held $16.3 million in cash and equivalents against $93.9 million of debt, a net debt position of $77.6 million.
The current ratio (current assets divided by current liabilities) was 4.58, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.15.
Summary generated from market data by MetaCap's automated system. Methodology
Precigen balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.33M | 7.48M | 30.23M | 14.32M | 13.76M | 6.06M | 29.52M | 24.73M | 9.35M | 17.48M | 7.58M | 10.08M |
| Short-Term Investments | 21.88M | 48.77M | 67.62M | 106.81M | 45.99M | 74.18M | 68.39M | 3.91M | 10.19M | 27.28M | 55.28M | 63.68M |
| Receivables | 71.87M | 26.40M | 3.92M | 580.00K | 327.00K | 751.00K | 926.00K | 479.00K | 511.00K | 872.00K | 902.00K | 988.00K |
| Inventory | 20.25M | 14.72M | 9.58M | 3.06M | — | — | 0 | — | — | — | — | — |
| Total Current Assets | 134.38M | 101.67M | 115.23M | 129.60M | 62.76M | 84.60M | 102.41M | 34.51M | 23.71M | 49.55M | 68.75M | 92.99M |
| Property, Plant & Equipment | 12.80M | 13.22M | 13.76M | 14.81M | 14.70M | 14.67M | 13.83M | 13.54M | 13.45M | 12.62M | 7.11M | 7.12M |
| Goodwill | 15.23M | 15.23M | 15.23M | 15.23M | 15.23M | 19.14M | 19.14M | 24.92M | 24.92M | 26.55M | 26.61M | 36.89M |
| Intangible Assets | 2.54M | 2.86M | 3.18M | 3.50M | 3.82M | 4.14M | 4.46M | 4.77M | 5.09M | 38.72M | 40.70M | 40.43M |
| Long-Term Investments | 490.00K | 489.00K | 2.51M | 2.51M | — | 750.00K | 0 | — | — | — | — | 5.27M |
| Total Assets | 170.30M | 138.63M | 155.50M | 171.26M | 101.90M | 128.79M | 145.27M | 83.47M | 73.16M | 134.85M | 151.04M | 190.69M |
| Accounts Payable | 5.30M | 2.59M | 11.98M | 6.26M | 3.92M | 3.11M | 3.53M | 4.32M | 4.85M | 4.72M | 1.73M | 2.35M |
| Short-Term Debt | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Current Liabilities | 29.35M | 21.10M | 37.31M | 32.07M | 23.19M | 23.99M | 21.52M | 21.22M | 23.02M | 28.77M | 22.98M | 32.88M |
| Long-Term Debt | 93.88M | 93.52M | 93.17M | 92.89M | — | — | 0 | — | — | — | — | — |
| Total Liabilities | 126.72M | 118.39M | 134.59M | 129.40M | 107.79M | 113.33M | 78.53M | 28.10M | 29.99M | 37.83M | 32.55M | 43.01M |
| Shareholders' Equity | 43.58M | 20.23M | 20.91M | 41.87M | -36.78M | -14.06M | 38.51M | 55.38M | 43.17M | 97.02M | 118.50M | 147.68M |
| Retained Earnings | -2.33B | -2.35B | -2.34B | -2.32B | -2.17B | -2.14B | -2.09B | -2.07B | -2.05B | -1.99B | -1.96B | -1.93B |
| Total Debt | 93.88M | 93.52M | 93.17M | 92.89M | — | — | 0 | — | — | — | 0 | 0 |
| Net Cash (Debt) | -55.67M | -37.27M | 4.68M | 28.25M | 59.75M | 80.24M | 97.91M | 28.63M | 19.54M | 44.76M | 62.85M | 73.75M |
| Shares Outstanding | 358.01M | 355.90M | 353.91M | 353.81M | 297.85M | 295.14M | 292.87M | 292.87M | 252.66M | 250.25M | 248.92M | 256.40M |
This table shows 12 quarterly periods of Precigen's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PGEN's reporting calendar. What is a balance sheet?